Benzinga | Nov 23, 2020 06:53AM EST

NovaBay Pharmaceuticals Expands Avenova's Geographic Reach to Australia with New Exclusive Distribution Agreement

NovaBay(r) Pharmaceuticals, Inc. (NYSE:NBY), a pharmaceutical company focusing on commercializing Avenova(r) for the eye care market, announces the signing of an agreement with Paragon Care Group Australia Pty Ltd for the exclusive distribution of Avenova in Australia. Paragon Care Group will begin distributing Avenova directly to consumers under its Designs For Vision brand beginning in early 2021.

"We are delighted to expand the geographic reach of Avenova with this agreement covering Australia," said Justin Hall, NovaBay CEO. "In Designs for Vision we have secured an ideal partner with a reputation for sourcing the highest quality products and an established market presence from more than 40 years of serving the ophthalmology and optometry sectors in Australia."

"Avenova fits extremely well with our portfolio of eye care products," said Nikolas Apostolou, General Manager of Designs for Vision. "It is the only commercially available pure hypochlorous acid lid and lash spray proven to be effective in eliminating the underlying cause of bacterial dry eye, yet Avenova is soothing, safe and effective for long-term use. We believe these qualities make Avenova the best product to treat the chronic bacterial infections that affect approximately 85% of all dry eye sufferers. We are thrilled to make this product available to Australians with dry eye disease."

Avenova previously received approval from the Australian Government Department of Health and was provided an Australian Register of Therapeutic Good Certificate for distribution in that country.